NCT05264922 - Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears | Biotech Hunter

Timeline

Start Date

January 9, 2022

Primary Completion Date

July 22, 2022

Study Completion Date

July 22, 2022

Conditions

Rotator Cuff Tears

Interventions

DRUG

Tisseel Injectable Product

Fibrin glue will provide an inert, biocompatible, viscous substance able to remain within the Rotator Cuff (RC) defect rather than injecting SVF cells in saline.

BIOLOGICAL

Stromal Vascular Fraction Cells

Stromal Vascular Fraction cells are autologously harvested, processed and reinjected into the affected shoulder.

Trial Locations (1)

32803

AdventHealth Orlando, Orlando